Arthur Raitano

2.9k total citations
28 papers, 1.7k citations indexed

About

Arthur Raitano is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Oncology. According to data from OpenAlex, Arthur Raitano has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Immunology and 8 papers in Oncology. Recurrent topics in Arthur Raitano's work include Immunotherapy and Immune Responses (6 papers), Prostate Cancer Treatment and Research (6 papers) and Immune Response and Inflammation (5 papers). Arthur Raitano is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Prostate Cancer Treatment and Research (6 papers) and Immune Response and Inflammation (5 papers). Arthur Raitano collaborates with scholars based in United States, Italy and Japan. Arthur Raitano's co-authors include Aya Jakobovits, Douglas C. Saffran, René Hubert, Charles L. Sawyers, Igor Vivanco, James Kuo, Emily Chen, Daniel Afar, Murray Korc and M Loda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Arthur Raitano

26 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arthur Raitano United States 16 650 540 486 427 261 28 1.7k
Yvon E. Cayre France 23 855 1.3× 533 1.0× 227 0.5× 437 1.0× 287 1.1× 38 2.0k
Graeme J. Dougherty United States 18 741 1.1× 472 0.9× 304 0.6× 603 1.4× 132 0.5× 44 2.0k
Bruce Freimark United States 17 997 1.5× 458 0.8× 240 0.5× 785 1.8× 65 0.2× 43 2.1k
Ines Gütgemann Germany 25 1.3k 2.0× 1.1k 2.0× 332 0.7× 1.2k 2.7× 181 0.7× 60 3.0k
Eugenio Gallo Italy 27 687 1.1× 548 1.0× 165 0.3× 489 1.1× 711 2.7× 94 2.3k
Audie Rice United States 17 832 1.3× 660 1.2× 126 0.3× 334 0.8× 535 2.0× 28 1.7k
Denise S. O’Keefe United States 21 691 1.1× 339 0.6× 786 1.6× 172 0.4× 111 0.4× 29 1.7k
Robert Silasi‐Mansat United States 24 594 0.9× 364 0.7× 160 0.3× 561 1.3× 281 1.1× 53 1.9k
A W Burgess Australia 15 666 1.0× 355 0.7× 138 0.3× 482 1.1× 245 0.9× 22 1.5k
Yasuto Akiyama Japan 27 878 1.4× 937 1.7× 270 0.6× 708 1.7× 102 0.4× 128 2.2k

Countries citing papers authored by Arthur Raitano

Since Specialization
Citations

This map shows the geographic impact of Arthur Raitano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Raitano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Raitano more than expected).

Fields of papers citing papers by Arthur Raitano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur Raitano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Raitano. The network helps show where Arthur Raitano may publish in the future.

Co-authorship network of co-authors of Arthur Raitano

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur Raitano. A scholar is included among the top collaborators of Arthur Raitano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur Raitano. Arthur Raitano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raitano, Arthur, W Kilby, Karen Morrison, et al.. (2025). Exploratory Rat Toxicology and Efficacy of the Boron Neutron Capture Therapy Drug Boronotyrosine in a Mouse Model of Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 123(5). 1395–1400.
2.
Morrison, Kendall, Pia M. Challita-Eid, Arthur Raitano, et al.. (2016). Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting SLITRK6 , a New Urothelial Cancer Biomarker. Molecular Cancer Therapeutics. 15(6). 1301–1310. 55 indexed citations
4.
Puro, Vincenzo, Silvia Pittalis, Carmela Protano, et al.. (2012). [Strategies for prevention and control of healthcare related infections by Acinetobacter baumannii].. PubMed. 23(6). 491–504. 1 indexed citations
5.
Gudas, Jean, Zili An, Karen Morrison, et al.. (2010). Abstract 4393: ASG-5ME is a novel antibody drug conjugate (ADC) for treating prostate cancers. Cancer Research. 70(8_Supplement). 4393–4393. 7 indexed citations
6.
Challita-Eid, Pia M., Kendall Morrison, Zili An, et al.. (2007). Monoclonal Antibodies to Six-Transmembrane Epithelial Antigen of the Prostate-1 Inhibit Intercellular Communication In vitro and Growth of Human Tumor Xenografts In vivo. Cancer Research. 67(12). 5798–5805. 87 indexed citations
7.
Jakobovits, Aya, Jean Gudas, Xiaofeng Jia, et al.. (2005). Therapeutic potential of AGS-PSCA: A fully human monoclonal antibody to prostate stem cell antigen (PSCA) for the treatment of prostate and pancreatic cancers. Journal of Clinical Oncology. 23(16_suppl). 4722–4722. 7 indexed citations
8.
Raitano, Arthur, et al.. (2004). [SARS: diagnosis, therapy, and especially prevention].. PubMed. 16(1-2). 211–24. 2 indexed citations
9.
Afar, Daniel, Igor Vivanco, René Hubert, et al.. (2001). Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia.. PubMed. 61(4). 1686–92. 199 indexed citations
10.
Gu, Zhen, George Thomas, Joyce M. Yamashiro, et al.. (2000). Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene. 19(10). 1288–1296. 361 indexed citations
11.
Hubert, René, Igor Vivanco, Emily Chen, et al.. (1999). STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proceedings of the National Academy of Sciences. 96(25). 14523–14528. 279 indexed citations
13.
Raitano, Arthur, Young E. Whang, & Charles L. Sawyers. (1997). Signal transduction by wild-type and leukemogenic Abl proteins. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1333(3). F201–F216. 84 indexed citations
14.
Raitano, Arthur & Murray Korc. (1993). Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors.. PubMed. 53(3). 636–40. 32 indexed citations
15.
Raitano, Arthur, Philip Scuderi, & Murray Korc. (1991). Upregulation of Interferon-γ Binding by Tumor Necrosis Factor and Lymphotoxin: Disparate Potencies of the Cytokines and Modulation of Their Effects by Phorbol Ester. Journal of Interferon Research. 11(1). 61–67. 17 indexed citations
16.
Raitano, Arthur, Philip Scuderi, & Murray Korc. (1990). Binding and Biological Effects of Tumor Necrosis Factor and Gamma Interferon in Human Pancreatic Carcinoma Cells. Pancreas. 5(3). 267–277. 40 indexed citations
17.
Raitano, Arthur, Philip Scuderi, & Murray Korc. (1990). Long-term effect of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells. International Journal of Pancreatology. 6(2). 109–118. 6 indexed citations
18.
Scuderi, Philip, Richard A. Rippe, Arthur Raitano, & James A. Rybski. (1989). Human Sera and Culture Supernatants From Human Tumors and Diploid Fetal Fibroblasts Suppress Tumor Necrosis Factor Secretion In Vitro. Journal of Leukocyte Biology. 46(1). 34–40. 2 indexed citations
19.
Scuderi, Philip, et al.. (1987). Recombinant Interferon-γ Stimulates the Production of Human Tumor Necrosis Factor In Vitro. Journal of Interferon Research. 7(2). 155–164. 29 indexed citations
20.
Pasquali, R., et al.. (1985). A controlled trial using ephedrine in the treatment of obesity.. PubMed. 9(2). 93–8. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026